Bailard Lowers stake in VCA Inc (WOOF)

VCA Inc (WOOF) : Bailard reduced its stake in VCA Inc by 0.3% during the most recent quarter end. The investment management company now holds a total of 47,675 shares of VCA Inc which is valued at $3,460,728 after selling 145 shares in VCA Inc , the firm said in a disclosure report filed with the SEC on Aug 8, 2016.VCA Inc makes up approximately 0.40% of Bailard’s portfolio.

Other Hedge Funds, Including , Saturna Capital Corp reduced its stake in WOOF by selling 6,148 shares or 0.98% in the most recent quarter. The Hedge Fund company now holds 620,000 shares of WOOF which is valued at $45,005,800. VCA Inc makes up approx 1.38% of Saturna Capital Corp’s portfolio.First Trust Advisors Lp boosted its stake in WOOF in the latest quarter, The investment management firm added 75,512 additional shares and now holds a total of 468,234 shares of VCA Inc which is valued at $33,525,554. VCA Inc makes up approx 0.10% of First Trust Advisors Lp’s portfolio.Clarivest Asset Management reduced its stake in WOOF by selling 17,900 shares or 32.7% in the most recent quarter. The Hedge Fund company now holds 36,839 shares of WOOF which is valued at $2,628,094. VCA Inc makes up approx 0.07% of Clarivest Asset Management’s portfolio.Alps Advisors Inc reduced its stake in WOOF by selling 528 shares or 6.81% in the most recent quarter. The Hedge Fund company now holds 7,231 shares of WOOF which is valued at $501,253.Calamos Wealth Management reduced its stake in WOOF by selling 4,772 shares or 59.05% in the most recent quarter. The Hedge Fund company now holds 3,309 shares of WOOF which is valued at $229,380. VCA Inc makes up approx 0.04% of Calamos Wealth Management’s portfolio.

VCA Inc opened for trading at $72.87 and hit $73.655 on the upside on Monday, eventually ending the session at $73.39, with a gain of 1.33% or 0.96 points. The heightened volatility saw the trading volume jump to 6,64,902 shares. Company has a market cap of $5,935 M.

On the company’s financial health, VCA Inc reported $0.87 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.82. The company had revenue of $653.49 million for the quarter, compared to analysts expectations of $637.18 million. The company’s revenue was up 19.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.70 EPS.

VCA Inc. is a national animal healthcare company operating in the United States and Canada. The Company operates in two segments: animal hospital and laboratory. The Company provides veterinary services and diagnostic testing to support veterinary care and also sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market. The Company provides communication marketing solutions and other services to the veterinary community. The Company’s animal hospital offer general medical and surgical services pharmaceutical products and performs pet wellness programs. The Company’s communication and marketing solutions business provides services to veterinary practices pharmaceutical manufacturers and the pet owning community. The Company’s network of veterinary diagnostic laboratories provides sophisticated testing and consulting services.

Leave a Reply

VCA Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on VCA Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.